Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
JUNS: Jupiter Neurosciences, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
JUNS
The Story
JUNS
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-23075.8%
ROIC
-455.4%
Financially safe
Stretched
Debt / equity
-1.74×
Interest coverage
-79.5×
Current ratio
0.51×
Jupiter Neurosciences, Inc.
JUNS
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Jupiter Neurosciences, Inc.
JUNS
NASDAQ
·
USD
·
Closed
$0.09
−7.69%
$0.09
−$0.01 (7.69%)
52W Range
0th
pctl
Volume
1.68×
avg
Mkt Cap
3.27M
USD
P/E
-0.4
TTM
Div Yield
–
ann
52W Range
0th
pctl
Volume
1.68×
avg
Market Cap
3.27M
USD
P/E Ratio
-0.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings